- Home
- AGNC vs LEGN Comparison
AGNC vs LEGN Comparison
Compare AGNC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- LEGN
- Stock Information
- Founded
- AGNC 2008
- LEGN 2014
- Country
- AGNC United States
- LEGN United States
- Employees
- AGNC N/A
- LEGN N/A
- Industry
- AGNC Real Estate Investment Trusts
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- AGNC Real Estate
- LEGN Health Care
- Exchange
- AGNC Nasdaq
- LEGN Nasdaq
- Market Cap
- AGNC 8.0B
- LEGN 7.0B
- IPO Year
- AGNC 2008
- LEGN 2020
- Fundamental
- Price
- AGNC $8.93
- LEGN $32.62
- Analyst Decision
- AGNC Buy
- LEGN Strong Buy
- Analyst Count
- AGNC 11
- LEGN 13
- Target Price
- AGNC $9.88
- LEGN $79.42
- AVG Volume (30 Days)
- AGNC 35.8M
- LEGN 1.5M
- Earning Date
- AGNC 04-21-2025
- LEGN 05-13-2025
- Dividend Yield
- AGNC 16.22%
- LEGN N/A
- EPS Growth
- AGNC N/A
- LEGN N/A
- EPS
- AGNC 0.40
- LEGN N/A
- Revenue
- AGNC $584,000,000.00
- LEGN $627,241,000.00
- Revenue This Year
- AGNC $40.90
- LEGN $65.96
- Revenue Next Year
- AGNC $19.18
- LEGN $52.55
- P/E Ratio
- AGNC $22.35
- LEGN N/A
- Revenue Growth
- AGNC N/A
- LEGN 119.97
- 52 Week Low
- AGNC $7.85
- LEGN $29.27
- 52 Week High
- AGNC $10.85
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- AGNC 50.52
- LEGN 45.91
- Support Level
- AGNC $8.61
- LEGN $30.25
- Resistance Level
- AGNC $8.92
- LEGN $35.81
- Average True Range (ATR)
- AGNC 0.16
- LEGN 1.41
- MACD
- AGNC 0.07
- LEGN -0.12
- Stochastic Oscillator
- AGNC 78.57
- LEGN 42.59
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.